Mark Bamforth is the founder of Arranta Bio. Latest round: Series B. Backed by IMA Industria Macchine Automatiche. Based in United States.
Mark Bamforth is the President & CEO at Arranta Bio. He previously founded and led Gallus BioPharmaceuticals and Brammer Bio, which are now part of Thermo Fisher Scientific. Bamforth recently led a $5M Series B financing round for CONTINUUS Pharmaceuticals Inc. and joined their Board of Directors, bringing decades of experience in commercial pharmaceutical manufacturing.
Full founder directory · Investor directory · Company funding database · Fundraising library